Showing 491-500 of 20360 results for "".
Part 2: A Plant-Based Diet for Preventing and Possibly Reversing Coronary Artery Disease
https://reachmd.com/programs/heart-matters/part-2-a-plant-based-diet-for-preventing-and-possibly-reversing-coronary-artery-disease/6332/Some evidence suggests it is possible to prevent and reverse heart disease by adhering to a plant-based diet, but lifestyle changes are often the most challenging for physicians to prescribe and for patients to adopt. What strategies can physicians use to encourage a plant-based diet for patients whA Look at LAI Antipsychotics for Bipolar I Disorder: A Preview of the Psych Congress
https://reachmd.com/programs/psych-congress-action-center/a-look-at-lai-antipsychotics-for-bipolar-i-disorder-a-preview-of-the-psych-congress/14192/Explore the benefits of long-acting injectable antipsychotics for bipolar disorder at this year’s Psych Congress.Optimizing Outcomes in Diabetic Limb Preservation
https://reachmd.com/programs/clinicians-roundtable/optimizing-outcomes-in-diabetic-limb-preservation/36427/Effective diabetic limb preservation is not only about preserving length. It's equally important to focus on functional outcomes, taking a patient-centered approach that considers key factors like mobility, age, dialysis status, and blood flow. Join Dr. Paul Kim as he discusses these decision-makingFinerenone Efficacy and Safety in Patients With CKD Regardless of Diabetes Status: Insights From the INFINITY Dataset
https://reachmd.com/clinical-practice/nephrology/finerenone-efficacy-and-safety-in-patients-with-ckd-regardless-of-diabetes-status-insights-from-the-infinity-dataset/57917/Explore efficacy and safety findings for finerenone in CKD across diabetes status using data from the INFINITY dataset that were presented at ERA 2026.Over-The-Counter Options for Diabetics
https://reachmd.com/programs/clinicians-roundtable/over-the-counter-options-for-diabetics/3756/Diabetes has become such a worldwide epidemic that some are turning to over-the-counter products as a way to help patients with this disease that has afflicted nearly 24 million in the U.S. alone. Dr. Gerald Bernstein, the vice president of medical affairs at Generex, a biotech company based in ToroBoston Legal's Christian Clemenson on Aspergers I
https://reachmd.com/programs/clinicians-roundtable/boston-legals-christian-clemenson-on-aspergers-i/1976/Christian Clemenson, or Jerry "Hands" Espenson from Boston Legal discusses with host Dr. Bill Rutenberg how he learned to play the role of a character with Aspergers Syndrome.Virtual Reality Simulation in Carotid Stenting I
https://reachmd.com/programs/clinicians-roundtable/virtual-reality-simulation-in-carotid-stenting-i/2089/Physicians at Emory recently developed a procedure that combines Virtual Reality with MRI to enable vascular surgeons to walk through a procedure using Virtual Realty minutes before they do the actual procudure. In this segment, join host, Dr. Mark Nolan Hill learn how this procedure was developedboonDOCS Medicine: The San Diego Wildfires I
https://reachmd.com/programs/clinicians-roundtable/boondocs-medicine-the-san-diego-wildfires-i/2341/Join Charles Wilson, Executive Director of the Chadwick Center at Rady Children's Hospital of San Diego and the crew from boonDOCS Medicine for "Out of the Ashes: Lessons Learned from the San Diego Wildfires!" In this segment, we'll discuss how to answer children's questions about potentially traumHot Topic: Can Global Warming Affect Diabetes Rates?
https://reachmd.com/programs/what-your-patients-are-talking-about/hot-topic-can-global-warming-affect-diabetes-rates/9593/Dr. Brian McDonough looks into a possible correlation between global warming and diabetes.Continuous Glucose Monitoring
https://reachmd.com/programs/diabetes-discourse/continuous-glucose-monitoring/4581/Technology continues to show great promise for people living with diabetes. One such technology is continuous glucose monitoring, a dynamic new technology with the potential to dramatically change the lives of type 1 diabetics and insulin-requiring type 2 diabetics. Join host Dr. Steven Edelman and